Zack Brown – Benefit-cost analysis and alternatives for evaluating biotechnology policy | GES Colloquium (ZOOM)
Is there a future role for benefit-cost analysis in biotechnology governance?
Is there a future role for benefit-cost analysis in biotechnology governance?